EGI
XENT

EAM Global Investors’s Intersect ENT, Inc XENT Stock Holding History

EAM Global Investors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-35,645
Closed -$1.4M – 196
2018
Q1 		$1.4M Hold
35,645
– – 0.73% 33
2017
Q4 		$1.16M Buy
+35,645
New +$1.07M 0.59% 57

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM Global Investors's XENT Position: Q2 2018 in Review

EAM Global Investors sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 35,645 shares — an estimated $1.4M sold.

EAM Global Investors first reported a position in XENT in Q4 2017 and held it in 2 quarters. The position peaked at $1.4M in Q1 2018. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • EAM Global Investors reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • EAM Global Investors sold 35,645 Intersect ENT, Inc shares in Q2 2018, an estimated $1.4M.
  • EAM Global Investors first reported a position in Intersect ENT, Inc in Q4 2017 and held it in 2 quarters.
  • EAM Global Investors's Intersect ENT, Inc position peaked at $1.4M in Q1 2018.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on EAM Global Investors's 13F filing for Q2 2018, filed 3 Aug 2018.